Last reviewed · How we verify
Unresectable urothelial carcinoma
Approved treatments
- Pembrolizuma · Memorial Sloan Kettering Cancer Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Unresectable urothelial carcinoma patent landscape — cliff calendar, originator estates, attackable patents
- Unresectable urothelial carcinoma treatment landscape brief
- Unresectable urothelial carcinoma treatment updates RSS
Frequently asked questions about Unresectable urothelial carcinoma
What drugs treat Unresectable urothelial carcinoma?
Tracked treatments include Pembrolizuma.
What is the treatment for Unresectable urothelial carcinoma?
Standard treatment for Unresectable urothelial carcinoma includes Pembrolizuma. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Unresectable urothelial carcinoma patent cliff · Unresectable urothelial carcinoma CI report
- Treatment: Pembrolizuma · Memorial Sloan Kettering Cancer Center
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing